Evaluation of the dose—response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension
2009 ◽
Vol 31
(12)
◽
pp. 2839-2850
◽
1993 ◽
Vol 125
(6)
◽
pp. 1704-1710
◽
2007 ◽
Vol 36
(1)
◽
pp. 26-31
◽
2019 ◽
Vol 10
(7)
◽
pp. 17
1993 ◽
Vol 33
(7)
◽
pp. 636-639
◽
Keyword(s):
2012 ◽
Vol 12
(1)
◽
pp. 35-47
◽
1998 ◽
Vol 38
(5)
◽
pp. 447-454
◽
2002 ◽
Vol 22
(1)
◽
pp. 9-15
◽